Micronized Palmitoylethanolamide Reduces the Symptoms of Neuropathic Pain in Diabetic Patients
Figure 1
Effect of micronized PEA on diabetic painful neuropathy evaluated by Michigan Neuropathy Screening Instrument (MNSI), Total Symptom Score (TSS), and Neuropathic Pain Symptoms Inventory (NPSI). ANOVA shows a significantly decreased pain intensity and symptom scores were observed by MNSI, TSS, and NPSI () during the treatment period and compared to baseline.